Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-B signaling pathway

Acta Pharmacologica Sinica

Volumn 33, Issue 2, 2012, Pages 242-249

  Jing, Li ^a   Lin, Shen ^a   Lu, Fu Rong ^a   You, Qin ^a   Rui, Chen ^a   Jia, Li ^b   Yan, Li ^a   Zhan, Han Zi ^d   He, Yuan Qiao ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c NANCHANG UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

anticancer drug; apoptosis; cisplatin; gastric carcinoma; NF B; plumbagin; TNF

Indexed keywords

CISPLATIN; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLUMBAGIN; PROTEIN BCL 2; PROTEIN BCL XL; SYNAPTOTAGMIN I; VASCULOTROPIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PLUMBAGO ZEYLANICA; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; I-KAPPA B KINASE; NAPHTHOQUINONES; NF-KAPPA B; PLUMBAGINACEAE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863158729     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.152     Document Type: Article

References (35)

1. Qiao L, Wong BC. Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist Update 2009; 12: 55-64.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
3. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-80.
4. Lu FR, Shen L, Qin Y, Gao L, Li H, Dai Y. Clinical observation on trigonella foenum-graecum L total saponins in combinaiton with sul phanylureas in the treatment of type 2 diabetes mellitus. Chin J Integr Med 2008; 14: 56-60.
5. Aziz MH, Dreckschmidt NE, Verma AK. Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone - refractory prostate cancer. Cancer Res 2008; 68: 9024-32.
6. Mossa JS, El-Feraly FS, Muhammad I. Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide. Phytother Res 2004; 18: 934-37. (Pubitemid 40052774)
7. Ding YX, Chen ZJ, Liu S, Che D, Vetter M, Chang CH. Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone. J Pharm Pharmacol 2005; 57: 111-6. (Pubitemid 40030109)
8. 2-M arrest and auto-phagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther 2006; 5: 3209-21.
9. Wang CC, Chiang YM, Sung SC, Hsu YL, Chang JK, Kuo PL. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375. S2 cells. Cancer Lett 2008; 259: 82-98. (Pubitemid 350245420)
10. Shieh JM, Chiang TA, Chang WT, Chao CH, Lee YC, Huang GY, et al. Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kappaB and AP-1 via ERK signaling pathway in A549 human lung cancer cells. Mol Cell Biochem 2010; 335: 181-93.
11. Sandur SK, Ichikawa H, Sethi G, Ahn KS, Aggarwal BB. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to poten tia-tion of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 2006; 281: 17023-33.
12. 2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J Pharmacol Exp Ther 2006; 318: 484-94.
13. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004; 6: 203-8.
14. Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metast Rev 2010; 29: 405-34.
15. Li Q, Yu YY, Zhu ZG, Ji YB, Zhang Y, Liu BY, et al. Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines. Eur Surg Res 2005; 37: 105-10. (Pubitemid 40864173)
16. Yamanaka N, Sasaki N, Tasaki A, Nakashima H, Kubo M, Morisaki T, et al. Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinoma. Anticancer Res 2004; 24: 1071-5. (Pubitemid 38624940)
17. Wu H, Li W, Wang T, Shu Y, Liu P. Paeoniforin suppress NF-kappaB activa tion through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells. Bio med Pharmacother 2008; 62: 659-66.
18. Zhao Q, Wang J, Zou MJ, Hu R, Zhao L, Qiang L, et al. Wogonin potentiates the antitumor effects of low dose 5-fuorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism. Toxicol Lett 2010; 197: 201-10.
19. Park HH, Lee KY, Kim SH, Lee YJ, Koh SH. L-DOPA-induced neuro toxi-city is reduced by the activation of the PI3K signaling pathway. Toxicology 2009; 265: 80-6.
20. Lv L, Xiao XY, Gu ZH, Zeng FQ, Huang LQ, Jiang GS. Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells. Mol Cell Biochem 2011; 346: 11-21.
21. Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood 2007; 110: 3517-25. (Pubitemid 350159615)
22. Li C, Yang Z, Zhai C, Qiu W, Li D, Yi Z, et al. Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathway. Mol Cancer 2010; 9: 73.
23. Olsen LS, Hjarnaa PJ, Latini S, Holm PK, Larsson R, Bramm E, et al. Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity. Int J Cancer 2004; 111: 198-205. (Pubitemid 38924696)
24. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, et al. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 1999; 274: 8531-8. (Pubitemid 29164643)
25. Yang F, Tang E, Guan K, Wang CY. IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 2003; 170: 5630-5. (Pubitemid 36617854)
26. Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS, et al. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther 2009; 8: 1360-8.
27. Ma YY, He XJ, Wang HJ, Xia YJ, Wang SL, Ye ZY, et al. Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer. Cancer Sci 2010; 102: 336-42.
28. Xie TX, Aldape KD, Gong W, Kanzawa T, Suki D, Kondo S, et al. Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor. Int J Oncol 2008; 33: 5-15.
29. Ducut Sigala JL, Bottero V, Young DB, Shevchenko A, Mercurio F, Verma IM. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 2004; 304: 1963-7. (Pubitemid 38822188)
30. Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res 2008; 68: 5370-9.
31. Liang Y, Xu RZ, Zhang L, Zhao XY. Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells. Acta Pharmacol Sin 2009; 12: 1659-65.
32. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 2006; 69: 195-206. (Pubitemid 43048906)
33. Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 2007; 102: 522-38. (Pubitemid 47000605)
34. Wang X, Chen W, Lin Y. Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways. Biochem Biophys Res Commun 2007; 355: 807-12. (Pubitemid 46330225)
35. Giri DK, Aggarwal BB. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen inter mediates. J Biol Chem 1998; 273: 14008-14. (Pubitemid 28268457)